FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, specifically to production of peptide anti-cancer agents, and can be used in medicine in treating or reducing oncological disease intensity. Cyclic polypeptide with SEQ ID NO: 3 is obtained from the C-terminus of acetylcholinesterase.
EFFECT: invention enables the effective therapy of oncological disease, including metastatic therapy.
7 cl, 18 dwg, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CANCER | 2017 |
|
RU2783416C2 |
| NEURODEGENERATIVE DISORDERS | 2015 |
|
RU2707191C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT OR PREVENTION | 2013 |
|
RU2631804C2 |
| ANTIBODY, WHICH RECOGNIZES PEPTIDE T14 ACHE | 2016 |
|
RU2729491C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2641260C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2633505C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2632645C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2639522C2 |
| SYNTHETIC PEPTIDES AND PREVENTIVE OR TREATMENT METHOD OF APPLICATION DURING CANCER INVASION AND METASTASIS | 2003 |
|
RU2346043C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT GROWTH | 2012 |
|
RU2595400C2 |
